QC
NMTC icon

Quent Capital’s NeuroOne Medical Technologies NMTC Stock Holding History

Quent Capital’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31 Hold
7
– – ﹤0.01% 1525
2025
Q4 		$30 Hold
7
– – ﹤0.01% 1559
2025
Q3 		$36 Buy
+7
New +$34 ﹤0.01% 1416

Other funds holding NMTC

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Quent Capital's NMTC Position: Q1 2026 in Review

Quent Capital held its NeuroOne Medical Technologies (NMTC) position steady in Q1 2026 at 7 shares worth $31. The position accounts for ﹤0.01% of the portfolio, ranked #1525.

Quent Capital first reported a position in NMTC in Q3 2025 and has held it in 3 quarters since. The position peaked at $36 in Q3 2025. 32 funds tracked by Wall St. Rank hold NMTC as of Q1 2026.

  • Quent Capital held 7 shares of NeuroOne Medical Technologies worth $31 as of Q1 2026.
  • Quent Capital left its NeuroOne Medical Technologies share count unchanged in Q1 2026.
  • NeuroOne Medical Technologies made up ﹤0.01% of Quent Capital's portfolio in Q1 2026, its #1525 holding.
  • Quent Capital first reported a position in NeuroOne Medical Technologies in Q3 2025 and has held it in 3 quarters since.
  • Quent Capital's NeuroOne Medical Technologies position peaked at $36 in Q3 2025.
  • 32 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.